129 related articles for article (PubMed ID: 12435282)
21. Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome.
Dreger P; Rieger M; Seyfarth B; Hensel M; Kneba M; Ho AD; Schmitz N; Pott C
Haematologica; 2007 Jan; 92(1):42-9. PubMed ID: 17229634
[TBL] [Abstract][Full Text] [Related]
22. New directions in the treatment of mantle cell lymphoma: an overview.
Goy A
Clin Lymphoma Myeloma; 2006 Oct; 7 Suppl 1():S24-32. PubMed ID: 17101070
[TBL] [Abstract][Full Text] [Related]
23. Combined administration of rituximab and on 013105 induces apoptosis in mantle cell lymphoma cells and reduces tumor burden in a mouse model of mantle cell lymphoma.
Prasad A; Shrivastava A; Papadopoulos E; Kuzontkoski PM; Reddy MV; Gillum AM; Kumar R; Reddy EP; Groopman JE
Clin Cancer Res; 2013 Jan; 19(1):85-95. PubMed ID: 23124440
[TBL] [Abstract][Full Text] [Related]
24. Mantle cell lymphoma: evolving management strategies.
Campo E; Rule S
Blood; 2015 Jan; 125(1):48-55. PubMed ID: 25499451
[TBL] [Abstract][Full Text] [Related]
25. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
26. Mantle cell lymphoma: clinicopathologic features and treatments.
Kauh J; Baidas SM; Ozdemirli M; Cheson BD
Oncology (Williston Park); 2003 Jun; 17(6):879-91, 896; discussion 896-8. PubMed ID: 12846128
[TBL] [Abstract][Full Text] [Related]
27. High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial.
Laurell A; Kolstad A; Jerkeman M; Räty R; Geisler CH
Leuk Lymphoma; 2014 May; 55(5):1206-8. PubMed ID: 23876100
[No Abstract] [Full Text] [Related]
28. Complete and durable remission of refractory mantle cell lymphoma with repeated rituximab monotherapy.
Ishiyama K; Takami A; Okumura H; Ozaki J; Shimadoi S; Yamanaka S; Nakao S
Int J Hematol; 2005 May; 81(4):319-22. PubMed ID: 15914363
[TBL] [Abstract][Full Text] [Related]
29. Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?
Geisler C; Kolstad A; Laurell A; Räty R; Nordic Lymphoma Group ; Mantle Cell Lymphoma Subcommittee
Leuk Lymphoma; 2009 Aug; 50(8):1249-56. PubMed ID: 19562619
[TBL] [Abstract][Full Text] [Related]
30. Current treatment approaches for mantle-cell lymphoma.
Witzig TE
J Clin Oncol; 2005 Sep; 23(26):6409-14. PubMed ID: 16155027
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen.
Galimberti S; Nagy B; Benedetti E; Pacini S; Brizzi S; Caracciolo F; Papineschi F; Ciabatti E; Guerrini F; Fazzi R; Canestraro M; Petrini M
Leuk Lymphoma; 2007 Aug; 48(8):1502-9. PubMed ID: 17701580
[TBL] [Abstract][Full Text] [Related]
32. [Ten years progression-free survival obtained in a patient with mantle cell lymphoma].
Wysokińska E; Kolak A; Starosławska E; Kieszko D; Kamińska M; Surdyka D; Mocarska A; Burdan F
Pol Merkur Lekarski; 2015 May; 38(227):280-2. PubMed ID: 26039024
[TBL] [Abstract][Full Text] [Related]
33. Mantle cell lymphoma.
Densmore JJ; Williams ME
Curr Treat Options Oncol; 2000 Aug; 1(3):281-5. PubMed ID: 12057172
[TBL] [Abstract][Full Text] [Related]
34. [Disappearance of CD 20 after treatment with rituximab of mantle cell lymphoma].
Yoshida K; Kayano H; Shimada T; Wakao D; Takahashi N; Sugahara Y; Yagasaki F; Ito Y; Kawai N; Matsuda A; Suzuki T; Bessho M
Rinsho Ketsueki; 2003 Mar; 44(3):174-81. PubMed ID: 12722344
[TBL] [Abstract][Full Text] [Related]
35. Primary gastric mantle cell lymphoma in a patient with long standing history of Crohn's disease.
Raderer M; Püspök A; Birkner T; Streubel B; Chott A
Leuk Lymphoma; 2004 Jul; 45(7):1459-62. PubMed ID: 15359648
[TBL] [Abstract][Full Text] [Related]
36. Current trials for frontline therapy of mantle cell lymphoma.
Steiner RE; Romaguera J; Wang M
J Hematol Oncol; 2018 Jan; 11(1):13. PubMed ID: 29374487
[TBL] [Abstract][Full Text] [Related]
37. An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma.
Jacobsen E; Freedman A
Curr Opin Oncol; 2004 Mar; 16(2):106-13. PubMed ID: 15075900
[TBL] [Abstract][Full Text] [Related]
38. Current treatment standards and emerging strategies in mantle cell lymphoma.
Dreyling M; Hiddemann W;
Hematology Am Soc Hematol Educ Program; 2009; ():542-51. PubMed ID: 20008239
[TBL] [Abstract][Full Text] [Related]
39. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic follow-up of 3 cases with gastrointestinal tract involvement of mantle cell lymphoma.
Saito M; Mori A; Irie T; Tanaka M; Morioka M; Ozasa M; Kobayashi T; Saga A; Miwa K; Tanaka S
Intern Med; 2010; 49(3):231-5. PubMed ID: 20118601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]